Pharmafile Logo

Curo

We are a global Pharma Market Access consultancy, with the core belief in adopting a collaborative approach to Payer engagement. Enabling you to speak to your Payer’s “in their language”.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Accession

Accession was a born from a passion and a vision. A passion to harness the power of market access to ensure patients gain access to life changing medicines and devices….

View Profile

Amiculum

AMICULUM works with the global healthcare industry to bring science to life across the product lifecycle from early opportunity assessment through to launch and beyond. By listening to the changing…

View Profile

Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop great pharmaceutical brands. We do this by creating Pharmacohesion™.

View Profile

Genesis Research Group

Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…

View Profile

Havas Life London

We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…

View Profile

Inizio

Welcome to Inizio. Your market-leading commercialization partner, providing tailored, innovative solutions to help health and life sciences companies with their clinical development and commercialization journeys, maximizing patient access.

View Profile

Onyx Health

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national and international reach. As we understand the healthcare market and…

View Profile

OPEN Health

OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.

View Profile

Origins – The Patient Focused Specialists

Origins creates and delivers patient focused strategy, insights, data and solutions, which guides pharma and biotech companies to improve value by involving patients throughout the entire product life cycle. We…

View Profile

Oxford PharmaGenesis

Oxford PharmaGenesis is an independently owned HealthScience communications consultancy, providing services to the healthcare industry, professional societies and patient groups.

View Profile

Red Thread Market Access Ltd

Blending brilliant writing with in-depth market access and reimbursement expertise

View Profile

Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…

View Profile

Uniphar

Uniphar Group is a trusted global partner to pharmaceutical, medtech, and supply chain and retail companies, working to improve patient access to medicines around the world.

View Profile

Visions4Health

Visions4Health are market access experts and your gateway to local adoption at pace. Leveraging our lived experience, understanding of national and local healthcare systems, and insights generated by our stakeholder…

View Profile

Company Details

Chilterns House, Dean Street, Marlow, SL7 3AA, UK
+44 (0) 1628 486 048

 Latest Content from PMHub 

Streamlining European expansion for cell and gene therapies

White Papers and Resources | September 16, 2025 | Uniphar

Tom Smith, Strategic Director, Cell and Gene Therapies, Uniphar, discusses the essential elements biotechs need for commercial success in Europe’s unique market when developing cell and gene therapies (CGTs). Europe...

Current CGT landscape and future outlook  

White Papers and Resources | September 16, 2025 | Uniphar

What makes CGT unique  Cell and gene therapy (CGT) is a unique treatment that uses cells and genetic material to treat and cure diseases. Personalized to the patient, CGT’s offer...

Building for Success: Aligning Preclinical and Phase 1 Strategy with Commercial Goals 

White Papers and Resources | September 16, 2025 | Uniphar

This article concludes our three-part series on preparing cell and gene therapies (CGTs) for successful launch and long-term viability. The first article explored the unique scientific and logistical challenges of...

Navigating the complexities of launch preparation for Cell and Gene Therapy

White Papers and Resources | September 16, 2025 | Uniphar

Cell and gene therapies (CGT) provide transformative treatment that can treat conditions that were previously considered untreatable. As described in the previous article in this series, most CGTs target patients...

Virtual Practice, Real Results: The Power of Virtual Patient Simulation

Press Releases | September 15, 2025 | Medscape Education

Simulation has never been more vital in medicine than it is today. As increasing numbers of physicians turn to large language models for clinical answers1, the real differentiator isn’t just...

A New Destination for Oncology Education

Press Releases | September 15, 2025 | Medscape Education

Medscape Oncology is pleased to announce the launch of a groundbreaking new learning space designed to provide education across tumor types and oncology disciplines: PIONEER – PrecIsion Oncology: Navigating EvidEnce...

A Call to Action: Bridging the Adult Immunization Divide

Press Releases | September 12, 2025 | Medscape Education

Over the past few years, as new diseases have emerged or reemerged, a host of new vaccines have become available while many others are in the pipeline. For older adults,...

ISPOR hosts expert webinar exploring the value of ECAs for regulatory and HTA evidence needs

Press Releases | September 12, 2025 | Genesis Research Group

On Tuesday, October 7th, you are invited to join a Genesis Research Group-led webinar exploring the value of External Control Arm (ECA) studies. Gaining traction as part of evidence generation...

Streamline Clinical Trial Collaboration – Engaging Your Advisors Creatively

Videos and Podcasts | September 11, 2025 | Impetus Digital

Boost efficiency in clinical operations! Learn a creative way to enhance communication between teams at different sites and streamline the development of study protocols, support materials, and journal submissions.

IPG Health expands Influencer ID marketing expertise into Europe

Press Releases | September 11, 2025 | IPG Health

Strategic rollout will scale US success into key European markets, strengthening the network’s leadership of social media strategy in the health/pharma sector